Literature DB >> 33573162

Molecules and Mechanisms to Overcome Oxidative Stress Inducing Cardiovascular Disease in Cancer Patients.

Francesco Sabbatino1,2, Valeria Conti1,3, Luigi Liguori4, Giovanna Polcaro1, Graziamaria Corbi5, Valentina Manzo1,3, Vincenzo Tortora4, Chiara Carlomagno4, Carmine Vecchione1,6, Amelia Filippelli1,3, Stefano Pepe1,2.   

Abstract

Reactive oxygen species (ROS) are molecules involved in signal transduction pathways with both beneficial and detrimental effects on human cells. ROS are generated by many cellular processes including mitochondrial respiration, metabolism and enzymatic activities. In physiological conditions, ROS levels are well-balanced by antioxidative detoxification systems. In contrast, in pathological conditions such as cardiovascular, neurological and cancer diseases, ROS production exceeds the antioxidative detoxification capacity of cells, leading to cellular damages and death. In this review, we will first describe the biology and mechanisms of ROS mediated oxidative stress in cardiovascular disease. Second, we will review the role of oxidative stress mediated by oncological treatments in inducing cardiovascular disease. Lastly, we will discuss the strategies that potentially counteract the oxidative stress in order to fight the onset and progression of cardiovascular disease, including that induced by oncological treatments.

Entities:  

Keywords:  ROS; antioxidative treatment; cardiotoxicity; cardiovascular disease; endothelial dysfunction; oncological treatments; oxidative stress

Year:  2021        PMID: 33573162      PMCID: PMC7911715          DOI: 10.3390/life11020105

Source DB:  PubMed          Journal:  Life (Basel)        ISSN: 2075-1729


  235 in total

Review 1.  Cytoplasmic signaling pathways that regulate cardiac hypertrophy.

Authors:  J D Molkentin; G W Dorn
Journal:  Annu Rev Physiol       Date:  2001       Impact factor: 19.318

2.  Differential activation of extracellular signal-regulated protein kinase 1/2 and p38 mitogen activated-protein kinase by AT1 receptors in vascular smooth muscle cells from Wistar-Kyoto rats and spontaneously hypertensive rats.

Authors:  R M Touyz; G He; M El Mabrouk; Q Diep; V Mardigyan; E L Schiffrin
Journal:  J Hypertens       Date:  2001-03       Impact factor: 4.844

3.  Comparison of New Glucose-Lowering Drugs on Risk of Heart Failure in Type 2 Diabetes: A Network Meta-Analysis.

Authors:  Caroline K Kramer; Chang Ye; Sara Campbell; Ravi Retnakaran
Journal:  JACC Heart Fail       Date:  2018-09-05       Impact factor: 12.035

4.  A systemic review on the antioxidant and anti-inflammatory effects of resveratrol, curcumin, and dietary nitric oxide supplementation on human cardiovascular health.

Authors:  Melissa J Banez; Matthew I Geluz; Anjali Chandra; Tesnim Hamdan; Olivia S Biswas; Nathan S Bryan; Ernst R Von Schwarz
Journal:  Nutr Res       Date:  2020-03-10       Impact factor: 3.315

5.  The effect of short-term celiprolol therapy on platelet function in essential hypertension.

Authors:  A Okrucká; J Pechán; I Balazovjech
Journal:  Cardiology       Date:  1993       Impact factor: 1.869

6.  Rapamycin attenuates atherosclerosis induced by dietary cholesterol in apolipoprotein-deficient mice through a p27 Kip1 -independent pathway.

Authors:  Claudia Castro; Josep M Campistol; David Sancho; Francisco Sánchez-Madrid; Elena Casals; Vicente Andrés
Journal:  Atherosclerosis       Date:  2004-01       Impact factor: 5.162

7.  Protection by beta-blocking agents against free radical-mediated sarcolemmal lipid peroxidation.

Authors:  I T Mak; W B Weglicki
Journal:  Circ Res       Date:  1988-07       Impact factor: 17.367

Review 8.  Endoplasmic reticulum stress and oxidative stress in cell fate decision and human disease.

Authors:  Stewart Siyan Cao; Randal J Kaufman
Journal:  Antioxid Redox Signal       Date:  2014-06-12       Impact factor: 8.401

Review 9.  Clinical pharmacokinetics and selective pharmacodynamics of new angiotensin converting enzyme inhibitors: an update.

Authors:  Jessica C Song; C Michael White
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 5.577

10.  β-AR blockers suppresses ER stress in cardiac hypertrophy and heart failure.

Authors:  Li Ni; Changqing Zhou; Quanlu Duan; Jiagao Lv; Xiangning Fu; Yong Xia; Dao Wen Wang
Journal:  PLoS One       Date:  2011-11-02       Impact factor: 3.240

View more
  5 in total

1.  Interferon-alpha2 treatment of patients with polycythemia vera and related neoplasms favorably impacts deregulation of oxidative stress genes and antioxidative defense mechanisms.

Authors:  Vibe Skov; Mads Thomassen; Lasse Kjær; Christina Ellervik; Morten Kranker Larsen; Trine Alma Knudsen; Torben A Kruse; Hans C Hasselbalch
Journal:  PLoS One       Date:  2022-06-30       Impact factor: 3.752

Review 2.  Adverse Events and Tolerability of Combined Durvalumab and Tremelimumab versus Durvalumab Alone in Solid Cancers: A Systematic Review and Meta-Analysis.

Authors:  Omar Fahmy; Osama A A Ahmed; Mohd Ghani Khairul-Asri; Nabil A Alhakamy; Waleed S Alharbi; Usama A Fahmy; Mohamed A El-Moselhy; Claudia G Fresta; Giuseppe Caruso; Filippo Caraci
Journal:  Biomedicines       Date:  2022-05-10

Review 3.  Exosomes: Potential Player in Endothelial Dysfunction in Cardiovascular Disease.

Authors:  Farahnaz Nikdoust; Mahboubeh Pazoki; Mohammadjavad Mohammadtaghizadeh; Mahsa Karimzadeh Aghaali; Mehran Amrovani
Journal:  Cardiovasc Toxicol       Date:  2021-10-20       Impact factor: 2.755

Review 4.  The Contribution of Gut Microbiota and Endothelial Dysfunction in the Development of Arterial Hypertension in Animal Models and in Humans.

Authors:  Jessica Maiuolo; Cristina Carresi; Micaela Gliozzi; Rocco Mollace; Federica Scarano; Miriam Scicchitano; Roberta Macrì; Saverio Nucera; Francesca Bosco; Francesca Oppedisano; Stefano Ruga; Anna Rita Coppoletta; Lorenza Guarnieri; Antonio Cardamone; Irene Bava; Vincenzo Musolino; Sara Paone; Ernesto Palma; Vincenzo Mollace
Journal:  Int J Mol Sci       Date:  2022-03-28       Impact factor: 5.923

5.  Design, Synthesis, and In Vitro Evaluation of Novel 8-Amino-Quinoline Combined with Natural Antioxidant Acids.

Authors:  Andrea Bacci; Francesca Corsi; Massimiliano Runfola; Simona Sestito; Ilaria Piano; Clementina Manera; Giuseppe Saccomanni; Claudia Gargini; Simona Rapposelli
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.